|TAC Regimen (Code C63435)|
|Terms & Properties|
Preferred Name: TAC Regimen
Definition: A regimen consisting of docetaxel, doxorubicin and cyclophosphamide used in the adjuvant setting for the treatment of breast cancer.
NCI-GLOSS Definition: An abbreviation for a chemotherapy combination used with other types of therapy to treat breast cancer. It includes the drugs docetaxel (Taxotere), doxorubicin hydrochloride (Adriamycin), and cyclophosphamide.
Label: TAC Regimen
NCI Metathesaurus Link: C1883257 (see NCI Metathesaurus info)
Synonyms & Abbreviations: (see Synonym Details)
External Source Codes:
|PDQ Closed Trial Search ID||657046|
|PDQ Open Trial Search ID||657046 (check for NCI PDQ open clinical trial info)|
|Name||Value (qualifiers indented underneath)|
|DesignNote||Source: NCCN Guidelines 2007|
|Semantic_Type||Therapeutic or Preventive Procedure|
Additional Concept Data:
|Defined Fully by Roles: No|